P21 (P021) vs Selank
CNTF-derived neurotrophic tetrapeptide mimetic that promotes neurogenesis, enhances BDNF expression, and demonstrates disease-modifying potential in Alzheimer's models
A clever brain-boosting peptide derived from your immune system's natural tuftsin molecule—it calms anxiety and sharpens your mind without the drowsiness or addiction risks of traditional anti-anxiety medications [1][4].
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Quick comparison
Dose range
P21 (P021)
500–1000 mcg
Selank
900–2700 mcg/day
Frequency
P21 (P021)
Once daily
Selank
3 times daily
Administration
P21 (P021)
Intranasal (spray)
Selank
Intranasal
Cycle length
P21 (P021)
8-12 weeks
Selank
14 days, repeatable after 1-3 weeks
Onset speed
P21 (P021)
Gradual (3-4 weeks)
Selank
Rapid (hours to days)
Evidence level
P21 (P021)
Strong preclinical (extensive animal studies)
Selank
Limited human trials
Benefit ratings
Cognitive
Anti-Aging
Healing & Recovery
Anxiety Relief
Cognitive Enhancement
Immune Support
Compound specifications
P21 (P021)
Molecular formula
C30H54N6O5
Molecular weight
578.3 g/mol
Half-life
>6 hours (for parent Peptide 6; P21 expected similar or improved due to adamantane modification)
Bioavailability
Orally bioavailable; BBB permeable (confirmed in preclinical studies)
CAS number
Not assigned (research compound)
Selank
Molecular formula
C33H57N11O9
Molecular weight
751.9 g/mol
Half-life
2-3 minutes (plasma); effects last hours due to downstream signaling
Bioavailability
High intranasal absorption; near 100% subcutaneous
CAS number
129954-34-3
Dosing compared
P21 (P021)
Selank
Intranasal
Registered label dose
900 mcg/day total (3 doses of 300 mcg)
2 drops in each nostril, 3 times daily · Registered label dose
The approved dose on the Russian registration (ЛРС-003338/09): 2 drops in each nostril, three times a day. At 75 mcg per drop that is 300 mcg per administration and 900 mcg across the day, taken as a 14-day course that can be repeated after 1-3 weeks [7]. Human evidence, registered label.
Highest dose studied
2,700 mcg/day total (3 doses of 900 mcg)
900 mcg (12 drops) 3 times daily · Highest dose studied
The top of the range the developing institute describes as optimal — single doses of 300-900 mcg, 900-2,700 mcg a day split across three administrations — and the dose used in the multicentre generalised-anxiety and neurasthenia trial, where 2,700 mcg/day was compared against medazepam 30 mg/day for 14 days [9]. Because the label caps a single administration at 2-3 drops per nostril, a 900 mcg dose is given as 2-3 drops per nostril with the rest 15 minutes later [7]. Human evidence, trial protocol.
Subcutaneous injection
Community suggestion — not a studied protocol
300-500 mcg per injection
Once daily · Community suggestion — not a studied protocol
Community-reported, not peer-reviewed. No human study has tested subcutaneous selank and the registered product is nasal drops only [7], so this range comes from community and clinical-practice reports rather than a trial — there is no published safety or effectiveness data behind it. Two things worth knowing before choosing the route. The nasal spray is absorbed almost completely, with 92.8% of the dose reaching the bloodstream within 30 seconds [7], so injecting is not a way to get more of the peptide in. And in mice, the injected and intranasal routes did not act the same: injection shifted GABA-receptor binding while the nasal route shifted NMDA-receptor binding instead, which the authors put down to how each route is absorbed and broken down [13]. That is animal work, and no one has checked whether the same split happens in people.
Best suited for
P21 (P021)
Neurogenesis and Brain Cell Renewal
P21 was specifically designed to promote adult hippocampal neurogenesis — the birth of new neurons in the brain's primary memory center. Preclinical studies demonstrate robust increases in neuronal progenitor cell proliferation and maturation of newborn neurons into functional, synaptically connected cells in the dentate gyrus.
Alzheimer's Disease Research
P21 shows remarkable disease-modifying potential in 3xTg-AD Alzheimer's mice: reducing tau hyperphosphorylation, lowering soluble Aβ levels, rescuing synaptic deficits, and restoring cognitive function over 12-month treatment periods. Its mechanism targets the underlying pathology rather than just symptoms.
BDNF Enhancement
For individuals seeking to boost brain-derived neurotrophic factor levels, P21 provides a targeted approach through its inhibition of LIF signaling, leading to sustained BDNF upregulation. BDNF is critical for synaptic plasticity, memory formation, and neuronal survival.
Long-Term Neuroprotection
With demonstrated safety in animal studies up to 12 months of continuous treatment and without the adverse effects of native CNTF, P21 is suited for extended neuroprotective protocols aimed at maintaining cognitive function during aging.
Selank
Anxiety Without the Fog
If traditional anti-anxiety medications leave you feeling sedated, foggy, or 'not yourself,' Selank offers a refreshing alternative. It calms anxious thoughts while keeping your mind sharp—like turning down the volume on worry without muting your brain [1].
Cognitive Performers
Students, professionals, and anyone facing demanding mental tasks love Selank for its dual action. It simultaneously reduces performance anxiety while enhancing memory and focus—the best of both worlds when you need to think clearly under pressure [1][2].
Stress Resilience Seekers
Chronic stress wreaks havoc on your brain. Selank helps protect against stress-induced cognitive decline by supporting BDNF levels and modulating your stress response [2]. Think of it as building a buffer between you and life's daily pressures.
Natural Approach Enthusiasts
Derived from tuftsin—a natural peptide your own immune system produces—Selank appeals to those seeking more 'natural' solutions [4]. It works with your body's existing systems rather than overriding them like synthetic drugs.
Side effects
P21 (P021)
Common
- Nasal irritation (intranasal route)
- Mild headache
- Mild fatigue during adjustment
Uncommon
- Vivid dreams
- Mood fluctuations
Serious
- No serious adverse effects observed in preclinical studies
Selank
Common
- Nasal irritation
- Mild fatigue
- Mild headache
- Injection site redness
Uncommon
- Vivid dreams
- Dizziness
Serious
- Allergic reaction
Safety & evidence
P21 (P021)
Evidence level
Strong preclinical (extensive animal studies)
FDA status
Research compound
Safety overview
P21 has demonstrated an excellent safety profile in preclinical animal studies, with up to 12 months of continuous treatment in mice showing no adverse effects. Critically, it does not produce the anorexia, hyperalgesia, and weight loss that limited clinical development of the parent molecule CNTF. The compound was specifically engineered to retain CNTF's neurotrophic benefits while eliminating its systemic side effects. No organ toxicity, tumorigenic effects, or behavioral abnormalities were reported in any published study.
Contraindications
- Known hypersensitivity to any component of the peptide formulation
- Pregnancy and breastfeeding — no reproductive safety data available
- Active brain tumors or history of CNS malignancies — neurogenesis-promoting compounds may theoretically affect tumor growth
- Children and adolescents — effects on developing brains not studied
Selank
Evidence level
Limited human trials
FDA status
Research compound
Safety overview
The safety record comes from small Russian trials, and the numbers are worth seeing. In the 62-person generalised-anxiety and neurasthenia trial, 30 people took selank at 2,700 mcg a day and 32 took medazepam 30 mg a day for 14 days; the two calmed anxiety about equally, and selank also reduced fatigue where the benzodiazepine did not [9]. A second trial of 60 people with phobic-anxiety and somatoform disorders compared it with phenazepam and reported a clear anxiolytic effect that lasted about a week after the last dose [3]. The registered label lists only two side effects — an unpleasant taste when the drops run from the nose into the throat, and allergic reactions in people sensitive to the ingredients — and records no cases of overdose, which it attributes to how fast the peptide breaks down [7]. Neither trial published a per-arm adverse-event rate, so there is no side-effect percentage to compare against placebo.
Contraindications
- Pregnancy or planning to become pregnant
- Currently breastfeeding
- Known allergy to peptide components
- Children and adolescents
- Severe psychiatric disorders requiring immediate intervention
Which is right for you?
Choose P21 (P021) if...
- Supporting neurogenesis and brain cell renewal in age-related cognitive decline
- Enhancing learning capacity and memory consolidation
- Neuroprotection through BDNF upregulation and tau pathology reduction
- Research into disease-modifying Alzheimer's disease therapies
Choose Selank if...
- Anxiety relief without sedation
- Cognitive enhancement and focus
- Memory improvement
- Stress resilience